Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRx-4DP0004 in Hospitalised Patients With COVID-19
NCT04363372Phase 2Withdrawn
- Sponsor
- 4D Pharma plc
- Start
- Aug 2020
- Primary completion
- Dec 2020
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of MRx-4DP0004 in coronavirus disease 2019 (COVID-19), sponsored by 4D Pharma plc. Planned start Aug 2020; status: withdrawn.
02
Drugs
MRx-4DP0004
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04363372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04363372.